These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Antipathy against SDD is justified: Yes. Timsit JF; Bassetti M Intensive Care Med; 2018 Jul; 44(7):1165-1168. PubMed ID: 29881989 [No Abstract] [Full Text] [Related]
26. Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit. Raineri E; Pan A; Mondello P; Acquarolo A; Candiani A; Crema L Am J Infect Control; 2008 May; 36(4):283-90. PubMed ID: 18455049 [TBL] [Abstract][Full Text] [Related]
27. Curtailing the spread of disease. Dunne ME; Greenough W Adv Nurse Pract; 2006 Jun; 14(6):63-6. PubMed ID: 16972462 [No Abstract] [Full Text] [Related]
28. Antimicrobial resistance: factors and outcomes. Fish DN; Ohlinger MJ Crit Care Clin; 2006 Apr; 22(2):291-311, vii. PubMed ID: 16678001 [TBL] [Abstract][Full Text] [Related]
29. A multi-society position paper on the prevention and management of nosocomial and severe infections: the Italian Society for Infectious Diseases, the Italian Multidisciplinary Society of Hospital Infections, the Italian Society of Chemotherapy, the Italian Society of Respiratory Medicine, the Italian Society of Clinical Microbiology, the Italian Society of Microbiology, and GISIG (Italian Study Group on Severe Infections). Ippolito G; Carosi G; Moroni M; Nicastri E; Lauria FN; Mazzotta F; Goglio A; Pea F; Blasi F; Fortina G; Rossano F Int J Infect Dis; 2010 Oct; 14 Suppl 4():S93-4. PubMed ID: 20708953 [No Abstract] [Full Text] [Related]
31. Europe, Austria and the battle against antimicrobial resistance. Hrabcik H Wien Klin Wochenschr; 2008; 120(9-10):253-4, 254-5. PubMed ID: 18545947 [No Abstract] [Full Text] [Related]
32. [Calculated and controlled pharmacotherapy of problem infections in intensive care patients]. Breithaupt H Zentralbl Chir; 1996; 121 Suppl():37-8. PubMed ID: 8967233 [No Abstract] [Full Text] [Related]
33. Health care-associated infection (HAI): a critical appraisal of the emerging threat-proceedings of the HAI Summit. Kollef MH; Napolitano LM; Solomkin JS; Wunderink RG; Bae IG; Fowler VG; Balk RA; Stevens DL; Rahal JJ; Shorr AF; Linden PK; Micek ST Clin Infect Dis; 2008 Oct; 47 Suppl 2():S55-99; quiz S100-1. PubMed ID: 18778223 [TBL] [Abstract][Full Text] [Related]
34. [The era of the classical bacterial epidemics is over. Today the challenge is from the "Domestic Germs"]. Heesemann J MMW Fortschr Med; 2005 Jan; 147(4):27-8. PubMed ID: 15745337 [No Abstract] [Full Text] [Related]
35. [Comparison of the use of antibodies in 1975 and 1978 in a regional hospital]. Toni M; Rosati G; Cuoghi I; Allevato F; Schito GC Ann Sclavo; 1981; 23(2):175-84. PubMed ID: 7325733 [TBL] [Abstract][Full Text] [Related]
36. [Two new forms of Augmentin and Ciblor, frequently used in the fight against cross infections]. Oudart N Rev Infirm; 1999 Apr; (48):55-6. PubMed ID: 10532085 [No Abstract] [Full Text] [Related]
37. [Antibiotic therapy in the third millenium]. Gómez J Rev Esp Quimioter; 2001 Jun; 14(2):198-202. PubMed ID: 11760710 [No Abstract] [Full Text] [Related]